Published in Invest Ophthalmol Vis Sci on September 19, 2012
Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxanthin: new results from the LUNA study. Invest Ophthalmol Vis Sci (2012) 1.51
MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A (2008) 3.33
A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol (2006) 2.90
Deferral of first review after uneventful phacoemulsification cataract surgery until 2 weeks: randomized controlled study. J Cataract Refract Surg (2007) 2.15
Physical activity and insulin sensitivity: the RISC study. Diabetes (2008) 2.03
Nutrient reference values for bioactives: new approaches needed? A conference report. Eur J Nutr (2013) 1.76
Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab (2007) 1.49
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Cancer Res (2002) 1.47
Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care (2013) 1.30
The impact of macular pigment augmentation on visual performance using different carotenoid formulations. Invest Ophthalmol Vis Sci (2012) 1.26
Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident. J Cataract Refract Surg (2004) 1.23
Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res (2006) 1.19
Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration. Surv Ophthalmol (2008) 1.19
Visual experiences during vitreous surgery under regional anesthesia: a multicenter study. Am J Ophthalmol (2005) 1.17
Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Neurobiol Aging (2013) 1.16
Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res (2006) 1.15
Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys (2004) 1.12
Supplementation with all three macular carotenoids: response, stability, and safety. Invest Ophthalmol Vis Sci (2011) 1.12
Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci (2008) 1.11
Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration. Br J Nutr (2012) 1.09
Psychophysical function in age-related maculopathy. Surv Ophthalmol (2009) 1.09
The prognostic influence of chronicity of rhegmatogenous retinal detachment on anatomic success after reattachment surgery. Am J Ophthalmol (2007) 1.02
Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in ireland. Cornea (2009) 1.01
The relationship between macular pigment and visual performance. Vision Res (2010) 1.01
Central retinal thickness is positively correlated with macular pigment optical density. Exp Eye Res (2005) 1.01
Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Curr Eye Res (2010) 1.00
Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension (2003) 0.98
Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci (2004) 0.98
Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration. Retina (2014) 0.97
Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res (2004) 0.97
The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS. Vision Res (2011) 0.97
Heritability of macular pigment: a twin study. Invest Ophthalmol Vis Sci (2005) 0.96
A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. Mol Nutr Food Res (2011) 0.96
The relationships between macular pigment optical density and its constituent carotenoids in diet and serum. Invest Ophthalmol Vis Sci (2007) 0.96
Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery. Invest Ophthalmol Vis Sci (2009) 0.95
Risk factors for age-related maculopathy. J Ophthalmol (2009) 0.95
Which approach for total hip arthroplasty: anterolateral or posterior? Clin Orthop Relat Res (2008) 0.94
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. Exp Eye Res (2012) 0.91
Arachidonic acid, palmitic acid and glucose are important for the modulation of clonal pancreatic beta-cell insulin secretion, growth and functional integrity. Clin Sci (Lond) (2004) 0.91
A central dip in the macular pigment spatial profile is associated with age and smoking. Invest Ophthalmol Vis Sci (2010) 0.91
Apolipoprotein E genotype is associated with macular pigment optical density. Invest Ophthalmol Vis Sci (2010) 0.90
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients. J Neurooncol (2015) 0.90
Macular pigment and its contribution to vision. Nutrients (2013) 0.90
Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest Ophthalmol Vis Sci (2008) 0.89
The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study. Invest Ophthalmol Vis Sci (2012) 0.89
Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not. Invest Ophthalmol Vis Sci (2012) 0.89
Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials. Ophthalmic Epidemiol (2014) 0.88
Measurement of macular pigment: Raman spectroscopy versus heterochromatic flicker photometry. Invest Ophthalmol Vis Sci (2005) 0.87
The economic benefit of hip replacement: a 5-year follow-up of costs and outcomes in the Exeter Primary Outcomes Study. BMJ Open (2012) 0.87
Ocular injury requiring hospitalisation in the south east of Ireland: 2001-2007. Injury (2010) 0.87
Cobalt from metal-on-metal hip replacements may be the clinically relevant active agent responsible for periprosthetic tissue reactions. Acta Biomater (2012) 0.87
Macular pigment and ocular biometry. Vision Res (2006) 0.86
Effect on refractive outcomes after cataract surgery of intraocular lens constant personalization using the Haigis formula. J Cataract Refract Surg (2010) 0.85
Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2014) 0.85
Measurement of macular pigment optical density using two different heterochromatic flicker photometers. Curr Eye Res (2007) 0.84
Candidate gene study of macular response to supplemental lutein and zeaxanthin. Exp Eye Res (2013) 0.84
Does pre-operative psychological distress affect patient satisfaction after primary total hip arthroplasty? BMC Musculoskelet Disord (2011) 0.84
The respective relationships between lipoprotein profile, macular pigment optical density, and serum concentrations of lutein and zeaxanthin. Invest Ophthalmol Vis Sci (2010) 0.83
Carotenoids and co-antioxidants in age-related maculopathy: design and methods. Ophthalmic Epidemiol (2008) 0.82
Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing. Ophthalmic Res (2010) 0.82
A lactate dehydrogenase ELISA-based assay for the in vitro determination of Plasmodium berghei sensitivity to anti-malarial drugs. Malar J (2012) 0.81
Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance. Exp Eye Res (2013) 0.81
Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res (2006) 0.81
Visual performance in patients with neovascular age-related macular degeneration undergoing treatment with intravitreal ranibizumab. J Ophthalmol (2013) 0.80
Menopause, insulin resistance, and risk factors for cardiovascular disease. Menopause (2006) 0.80
Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids. Ophthalmology (2013) 0.80
Prognostic indicators and outcome measures for surgical removal of symptomatic nonadvanced cataract. Arch Ophthalmol (2011) 0.80
The natural history of tractional cystoid macular edema. Retina (2012) 0.80
An evaluation of a novel instrument for measuring macular pigment optical density: the MPS 9000. Acta Ophthalmol (2011) 0.80
Uncorrected visual acuity in the immediate postoperative period following uncomplicated cataract surgery: bimanual microincision cataract surgery versus standard coaxial phacoemulsification. Int Ophthalmol (2008) 0.80
The heritability of the ring-like distribution of macular pigment assessed in a twin study. Invest Ophthalmol Vis Sci (2014) 0.79
The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype. Exp Eye Res (2011) 0.79
Development of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals. J Clin Microbiol (2005) 0.79
Urinary excretion of purine derivatives as an index of microbial protein synthesis in the camel (Camelus dromedarius). Br J Nutr (2004) 0.79
Fetal biometry: does patient ethnicity matter? J Matern Fetal Neonatal Med (2013) 0.78
Changes in macular pigment optical density and serum concentrations of lutein and zeaxanthin in response to weight loss. Br J Nutr (2010) 0.78
Grading of age-related maculopathy: slit-lamp biomicroscopy versus an accredited grading center. Retina (2009) 0.78
Macular carotenoids and age-related maculopathy. Ann Acad Med Singapore (2006) 0.78
Value of dual biometry in the detection and investigation of error in the preoperative prediction of refractive status following cataract surgery. Clin Experiment Ophthalmol (2010) 0.78
Diet and risk factors for age-related maculopathy. Am J Clin Nutr (2008) 0.78
Advancing cytometry for immunology. Eur J Immunol (2012) 0.78
Pre-operative psychological distress does not adversely affect functional or mental health gain after primary total hip arthroplasty. Hip Int (2011) 0.77
Surgically induced astigmatism after phacoemulsification with and without correction for posture-related ocular cyclotorsion: randomized controlled study. J Cataract Refract Surg (2010) 0.77
Impact of dietary carotenoid deprivation on macular pigment and serum concentrations of lutein and zeaxanthin. Br J Nutr (2012) 0.76
New trends in cytometry in the era of systems biology. Cytometry A (2008) 0.76
Education is positively associated with macular pigment: the Irish Longitudinal Study on Ageing (TILDA). Invest Ophthalmol Vis Sci (2012) 0.76
Surgical and visual outcomes following exchange of opacified Hydroview intraocular lenses. Br J Ophthalmol (2006) 0.75
Discussion of changes in intraocular pressure and anterior segment morphometry following phacoemulsification cataract surgery. Arch Ophthalmol (2012) 0.75
Visual sensation during vitrectomy under retrobulbar anesthesia. Am J Ophthalmol (2006) 0.75
Visual sensations during vitrectomy. Ophthalmology (2007) 0.75
Macular pigment: its associations with color discrimination and matching. Optom Vis Sci (2011) 0.75